Australian lawyers warn pharmacies of growing legal risk from peptide boom
The Australian Journal of Pharmacy reports that businesses supplying peptides face rising exposure as demand outpaces regulatory clarity.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 24 16:01 ETSource: Australian Journal of Pharmacy
The wire
- 01Lawyers quoted by the Australian Journal of Pharmacy say the peptide boom poses a growing risk to businesses operating in the space.
- 02Pharmacies and clinics compounding or supplying peptides are the audience for the warning, which points to liability tied to unapproved products.
- 03Specific enforcement actions, regulator statements and the legal tests involved are not set out in the report.
From the source
Read at ajp.com.auPeptide boom poses ‘growing risk’ to businesses: lawyers
